News|Articles|March 15, 2020

A Practical Approach to Pharmacopoeia Compliance

Author(s)J. Mark Wiggins, Joseph A. Albanese

This article presents a case study at the intersection of monograph development and compliance.

External Link - PTebook0320_024-032_PharmacopeiaCompendia_Part10_PracticalApproach.pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

PharmTech Weekly Roundup—July 17, 2026

BySusan Haigney

July 20th 2026

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

ByBrian Drapeau

July 16th 2026

Topical Corticosteroid Bioequivalence Guidance Ends 30-Year Wait

The Implications of the FDA’s New Finalized Guidance Documents

ByZachary Zubulake

July 16th 2026

FDA concept. Concept of the Food and Drug Administration. Magnifier glass, folder and clock | Image credit: © Sviatlana - © Sviatlana-stock.adobe.com

Using Risk-Based Quality Frameworks to Fast-Track Biopharma Development: A Q&A with Abzena’s Jeffrey C. Mocny and Cellares’ Anna McMahon

ByFeliza Mirasol,Jeffrey C. Mocny,Anna McMahon

July 15th 2026

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS) | © Tada Images - stock.adobe.com (521699065)

FDA Activity Round Up – July 2026

ByZachary Zubulake

July 15th 2026

A Practical Approach to Pharmacopoeia Compliance

Related Content

PharmTech Weekly Roundup—July 17, 2026

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

The Implications of the FDA’s New Finalized Guidance Documents

Using Risk-Based Quality Frameworks to Fast-Track Biopharma Development: A Q&A with Abzena’s Jeffrey C. Mocny and Cellares’ Anna McMahon

FDA Activity Round Up – July 2026

Trending on Pharmaceutical Technology

Everything to Know about BMS & NVidia’s AI Supercomputer

Can AI Fix Pharma's Last-Mile Delivery Blind Spot?

From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026

PharmTech Weekly Roundup—July 17, 2026

Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory